Skip to main content
Equibles

VIJAYA · Vijaya Diagnostic Centre Limited

Use VIJAYA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VIJAYA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
1,410.55 INR -3.75 (-0.27%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 1969 Avg daily vol (3M) 11.05K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Investor day
Close1,410.55 INR Open1,419.20 INR Day1,401.60–1,430.95 INR 52W close861.45–1,567.85 INR Avg vol 30d10K Last earningsNov 4, 2026 DataSep 2021–Nov 2026

Latest documents

2026
Nov 4
Earnings call
Revenue grew 26.7%, EBITDA rose 37.8% amid expansion

Vijaya Diagnostic Centre Limited reported Q2 FY '27 revenue of INR 255 crore, up 26.7%, while EBITDA grew 37.8%. It targets 8 hubs and 14 spokes by Q1 FY '28 and expects at least 20% revenue growth.

5 source passages
Q2 FY '27, I am pleased to share that we have sustained our strong growth momentum with healthy contributions from across geographies. Consolidated revenue for the current quarter stood at approximately INR 255 crore, registering a strong year-on-year growth of 26.7%. EBITDA for the current quarter stood at approximately INR 113 crore compared to INR 82 crore in the corresponding quarter of the previous year, registering a strong year-on-year growth of 37.8%. We will be launching 8 hub centers along with 14 spokes by Q1 FY '28. we will be growing at least like a 20% growth rate is fairly achievable for this financial year. Open the document at this passage
All documents

Quarterly results

Revenue Net income Net loss
▲27.3% 1.69B INR 351.56M INR '25 Q3 ▲11.6% 1.73B INR 346.37M INR '25 Q4 ▲20.4% 1.88B INR 383.39M INR '26 Q1 ▲10.2% 2.02B INR 432.83M INR '26 Q2 ▲21.4% 2.05B INR 431.75M INR '26 Q3 ▲26.6% 2.19B INR 479.29M INR '26 Q4 ▲22.8% 2.31B INR 531.01M INR '27 Q1 LATEST ▲26.7% 2.55B INR 594.74M INR '27 Q2

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Price context
position in its 52-week range
Range low 861.45 INR Now 1,410.55 INR · 78% Range high 1,567.85 INR
vs 200-day avg +12% vs 50-day avg -3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Performance

5D 20D 120D MTD YTD
XBOM:VIJAYA -4.0% +2.1% +15.5% -2.5% +32.8%

Exchange listing

Market
XBOM
Ticker
VIJAYA
ISIN
INE043W01024
Security
Ordinary share
Trading currency
INR

Company

Website
https://vijayadiagnostic.com/
Investor relations
https://www.vijayadiagnostic.com/investors/disclosure-Regulation-SEBI-Regulations-2015

Other listings of this company

Share classes and depositary receipts can have different prices and dividends.

Recent dividends

Ex-dividend dateAmount per share
2026-09-16 2.00 INR
2025-08-29 2.00 INR
2024-08-30 1.00 INR
2023-09-13 1.00 INR
2022-09-20 1.00 INR

Upcoming investor events

No upcoming investor events are listed for this company yet.

Earnings calls

  • Earnings call · Q2 2027 2026-11-04 Transcript
    Earnings Call for the Quarter Ended September 30, 2026
  • Earnings call · Q1 2027 2026-08-07 Transcript
    Earnings Call for the Quarter Ended June 30, 2026
  • Earnings call · Q4 2026 2026-05-08 Transcript
    Earnings Call for the Quarter Ended March 31, 2026